A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
KaliVir Immunotherapeutics
Psyence Australia Pty Ltd
Pfizer
Tizona Therapeutics, Inc
Second Life Therapeutics
Elephas
Novartis
Elephas
Degron Therapeutics Co.
AstraZeneca
Massive Bio, Inc.
Sensei Biotherapeutics, Inc.
Delfi Diagnostics Inc.
Genentech, Inc.
DEKA Biosciences
Tempus AI
Taproot Health
Inhibrx Biosciences, Inc
Sanguine Biosciences
Celldex Therapeutics
AO GENERIUM
Shanghai Yunying Medical Technology
Kineta Inc.
Bristol-Myers Squibb
Quadriga Biosciences, Inc.
Pfizer
Novartis
Fate Therapeutics
SpeciCare
Celgene
Celldex Therapeutics
Santa Maria Biotherapeutics
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Pharmacyclics LLC.
Altor BioScience
Cytheris SA
Mirror Biologics, Inc.
ZymoGenetics
NS Pharma, Inc.